CST6 and plasma cell myeloma: CST6, an extracellular polypeptide inhibitor of cysteine proteases, also affects bone metastasis by regulating osteoclastogenesis in many cancers, such as breast cancer and multiple myeloma (Li et al., 2021; Gai et al., 2022).